Cancer combo therapy under the microscope: real-world study launched
NCT ID NCT07665736
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will observe 200 cancer patients who are already receiving immunotherapy (immune checkpoint inhibitors) along with radiotherapy. Researchers want to see how long the cancer stays under control and how patients fare overall, in everyday clinical practice rather than a strict lab setting. The goal is to gather practical evidence on effectiveness and safety to help doctors make better treatment choices.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- immune checkpoint inhibitors combined with radiotherapy
- What this could lead to
- If successful, this study could provide real-world evidence to guide better treatment decisions for cancer patients using immunotherapy and radiotherapy together.
- What could go wrong
- This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may vary widely due to the diverse patient population and treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNE CHECKPOINT INHIBITORS (ICIS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
West China Hospital of Sichuan University
Chengdu, 610041, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple supplement soothe Radiation-Damaged rectums?
- Can imaging reveal how radiation shapes marrow recovery?
- Can a targeted drug combo boost chemoradiation in EGFR-Positive lung cancer?
- A shield for bone marrow: can a drug stop Chemo's blood cell side effect?
- Can a video call replace a clinic visit for cancer patients on radiotherapy?
- New imaging agent could sharpen cancer detection